CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving the treatment of visceral leishmaniasis by developing new tools to assess drug resistance and innovative methods to monitor treatment effectiveness. It aims to ensure the quality and availability of existing drugs while supporting the elimination program in the Indian sub-continent.
Visceral leishmaniasis (VL), one of the most-neglected infectious diseases, has an annual incidence of 500,000 cases.
Early treatment is a major pillar of the current program for VL elimination on the Indian sub-continent.
However, the arsenal of available drugs is very limited, and their use is jeopardized by drug resistance.
Combination regimens for VL are under clinical development, but it will take several more years to change the drug policy.
Meanwhile, the effectiveness of current drugs ne…
INSTITUUT VOOR TROPISCHE GENEESKUNDE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Glasgow
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Antwerpen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Germany, Berlin
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
